1-14 of 14
beijing
Close
Sort by
Journal Articles

Safety, Tolerability and Efficacy of Orelabrutinib, Once a Day, to Treat Chinese Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Cell Leukemia

Wei Xu, MD PhD, Yongping Song, Zengjun Li, Shenmiao Yang, Lihong Liu, Yu Hu, Wei Zhang, Jianfeng Zhou, Sujun Gao, PhD, Kaiyang Ding, Huilai Zhang, MD, Zunmin Zhu, MD, Shunqing Wang, Bing Xu, Jianda Hu, PhD, Ting Liu, MD, Chunyan Ji, Zhongjun Xia, MD, Yan Li, PhDMD, Xin Wang, MD PhD, Zhixin Xu, Renbin Zhao, Bin Zhang, PhD, Alan Zhu, Jianyong Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4319.
https://doi.org/10.1182/blood-2019-123331
Published: 2019
Journal Articles

Prevalence of Monoclonal Gammopathy of Undetermined Significance in a Large Population with Annual Physical Examination in Beijing, China

Jinuo Wang, MD, Jian-Hua Han, Yue-lun Zhang, Xin-xin Cao, Dao-Bin Zhou, Teng-da Xu, Wei Su, Jian Li, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5519.
https://doi.org/10.1182/blood-2019-124715
Published: 2019
Journal Articles

Long-Term Follow-up of Hematopoietic Stem Cell Transplantation with the Modified Peking Regimen for the Treatment of Acute Leukemia

Xi Yang, Chenglong Li, MDand PhD, Rong Zhang, MDand PhD, Hong Zheng, MD PhD, Qing Wei, MD PhD, Chunsen Wang, MD, Jingying Dai, PhD, Xiaobing Huang, Ningning Tang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2034.
https://doi.org/10.1182/blood-2019-124419
Published: 2019
Journal Articles

Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study

Yuqin Song, MD PhD, Quanli Gao, MD, Huilai Zhang, PhD, Lei Fan, MD PhD, Jianfeng Zhou, PhD, Dehui Zou, MD, Wei Li, MD, Haiyan Yang, PhD, Ting Liu, MD, Quanshun Wang, MD PhD, Fangfang Lv, MD, Yu Yang, MD, Haiyi Guo, MD, Liudi Yang, MD, Rebecca Elstrom, MD, Jane Huang, MD, William Novotny, MD, Vivian Wei, PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 682.
https://doi.org/10.1182/blood-2018-99-117848
Published: 2018
Journal Articles

Comparable Outcomes after Hematopoietic Stem Cell Transplantation from Mother Donors and Matched Unrelated Donors in Patients with Hematopoietic Malignancies

Rui MA, Xiao-Jun Huang, Lan-Ping Xu, Kaiyan Liu, Xiaohui Zhang, MD, Chen-Hua Yan, Wei Han, Feng-Rong Wang, Yu-Hong Chen, Huan Chen, Yao Chen, MD, Jing-Zhi Wang, Yu Wang
Journal: Blood
Blood (2018) 132 (Supplement 1): 3463.
https://doi.org/10.1182/blood-2018-99-113961
Published: 2018
Journal Articles

Assessment of Standardization and International Scale (IS) Alignment Efforts of BCR-ABL1 Testing By the Chinese CML Alliance in an International External Quality Assessment Program

Ya-Zhen Qin, Stuart Scott, Dao-Xin Ma, Jian-Nong Cen, Cong Han, Min Xiao, MD PhD, Jordan Clark, Peng Zhao, Biao Yin, Annie Tapley, Debbie Travis, Liam Whitby, David Barnett, Xiao-Jun Huang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2890.
https://doi.org/10.1182/blood.V130.Suppl_1.2890.2890
Published: 2017
Journal Articles

The Clinical Significance of Monitoring Expression Level of Sil-TAL1 Fusion Gene after Allogeneic Hematopoietic Stem Cell Transplantation

Xiaosu Zhao, Dr., Yan Hong, Yazhen Qin, Yingjun Chang, PhD, Xiaohui Zhang, Lanping Xu, Xiao Jun Huang, MD and, professor
Journal: Blood
Blood (2016) 128 (22): 5800.
https://doi.org/10.1182/blood.V128.22.5800.5800
Published: 2016
Journal Articles

Haploidentical Stem Cell Transplantation for Rare Pediatric Diseases at Peking University People's Hospital

Yao Chen, MD, Huan Chen, MD, Lan-Ping Xu, Yu-Hong Chen, Jing-Zhi Wang, Feng-Rong Wang, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang
Journal: Blood
Blood (2016) 128 (22): 5848.
https://doi.org/10.1182/blood.V128.22.5848.5848
Published: 2016
Journal Articles

First prospective clinical trial in adult HLH

Clinical Trials & Observations
Paul La Rosée
Journal: Blood
Blood (2015) 126 (19): 2169–2171.
https://doi.org/10.1182/blood-2015-09-666503
Published: 2015
Journal Articles

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

Ya-Zhen Qin, Honghu Zhu, Qian Jiang, Hao Jiang, Le-Ping Zhang, Jin-Lan Li, Ling-Di Li, Yan-Rong Liu, Yue-Yun Lai, Hong-Xia Shi, Bin Jiang, MD, Xiao-Jun Huang, MDPhD
Journal: Blood
Blood (2014) 124 (21): 1000.
https://doi.org/10.1182/blood.V124.21.1000.1000
Published: 2014
Journal Articles

Minimal Residual Disease Monitoring By Quantitative RT-PCR In t (8; 21) AML Early After Allogeneic HSCT Can Predict Clinical Outcomes and Allow Further Risk Stratification

Yu Wang, Yanrong Liu, Yazhen Qin, Xiao-Jun Huang, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 3386.
https://doi.org/10.1182/blood.V122.21.3386.3386
Published: 2013
Journal Articles

Families get mobilized to treat AML

Stephen Mackinnon, Ronjon Chakraverty
Journal: Blood
Blood (2011) 117 (3): 746–748.
https://doi.org/10.1182/blood-2010-11-315929
Published: 2011
Journal Articles

Clinical Report on 6 Children with Hematopoietic Disease with Umbilical Cord Blood Transplantation.

Jing Chen, MD, PhD, Long-Jun Gu, MD, Lu Dong, MD, JingYan Tang, MD., Ph.D, Yao-Ping Wang, MD.
Journal: Blood
Blood (2005) 106 (11): 5447.
https://doi.org/10.1182/blood.V106.11.5447.5447
Published: 2005
Journal Articles

Current Activities of AsiaCORD: Fast Searching System of the Qualified Cord Blod Units for Asian Patients.

Tsuneo A. Takahashi, D.Sc, Kai Hsin Lin, MD, Hoon Han, MD, Tran van Binh, MD, Nguyen Tan Binh, MD, Zhongchao Han, MD, Kai Yan Liu, MD, Surapol Issaragrisil, MD, Hideki Kodo, MD, Shigetaka Asano, MD, Dao Pei Lu, MD
Journal: Blood
Blood (2004) 104 (11): 5008.
https://doi.org/10.1182/blood.V104.11.5008.5008
Published: 2004